01 / Development Ready
Engineering complete
Facility design, engineering, and regulatory planning are complete, enabling the next phase of construction.
Born in the Netherlands, grown in Colombia
Connecting Cannabis Production to European Pharmaceutical Markets
CannHill integrates pharmaceutical cultivation, strict European governance, and regulated international distribution into a single platform engineered for scale.
10 HA
Facility footprint
GACP/GMP
Compliance standard
3
Corporate entities
Cultivation facility — Antioquia, Colombia02 / Fully Licensed
Regulatory approvals
Cultivation, manufacturing, and export licenses secured for regulated international pharmaceutical markets.
03 / Export Aligned
GMP standards
Designed around European GMP compliance and direct international distribution.
Strategic Advantages
Why CannHill?
Combining European operational holding standards with ultra-low-cost equatorial production environments.
01
European Governance
Structured under a Dutch holding framework, providing predictable investor oversight, legal transparency, and institutional asset protection.
02
Cost Leadership
Indoor-grade flower quality at greenhouse operational costs, leveraging Colombia's equatorial sunlight and natural climate advantage.
03
Regulatory Readiness
End-to-end licensing aligned with international narcotic boards, supporting import and distribution permits across the EU.
04
Scalable Platform
Modular expansion capacity built to supply Europe's regulated pharmaceutical markets reliably, year-round.
Corporate Architecture
Built for European Pharmaceutical Markets
CannHill's international operating model unifies European corporate governance, Colombian production, and direct European distribution.
Holding & Governance
Agritech Invest Holding BV
Netherlands
Investment is held through Agritech Invest Holding BV in the Netherlands, providing stable governance, capital oversight, and a familiar and favorable European investment structure.
Financial & Legal HQ
Cultivation & Processing
CannHill SAS
Colombia
Pharmaceutical-grade cultivation and processing are carried out by CannHill SAS in Colombia, combining world-class growing conditions with GACP and GMP standards.
Production Facility
Commercial Distribution
CannHill Global Distribution BV
Netherlands
CannHill Global Distribution BV coordinates commercial operations, quality assurance, regulatory compliance, and European market access, enabling efficient distribution across regulated pharmaceutical markets through GDP and GMP partners.
EU Market Access
Investor Alignment
Building the Future of Pharmaceutical Cannabis
Commercial value is consolidated directly within the European operating platform, aligning governance, risk mitigation, and long-term shareholder value creation.
- EU-GMP Aligned
- Institutional Governance
- Scalable OPEX Model